Vertex Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2009
Total Assets: $1.96B
Liabilities Breakdown FY2009
Total Liabilities: $859.1M
Asset Breakdown
Total Assets: $1.96B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $446.7M | 22.8% |
| Accounts Receivable | $9.6M | 0.5% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $62.3M | 3.2% |
| Goodwill | $26.1M | 1.3% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.41B | 72.1% |
Liabilities Breakdown
Total Liabilities: $859.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $37.0M | 4.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $822.2M | 95.7% |